Close

Indian Immunologicals Ltd donates Oxygen Generation Plant to Telangana Institute of Medical Sciences (TIMS) and Research, Gachibowli

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Indian Immunologicals Limited (IIL) – a leading vaccine manufacturer, donated a PSA Oxygen Generation Plant to the Telangana Institute of Medical Sciences (TIMS), Gachibowli for service to patients in need of Oxygen support.

IIL had facilitated the setup of an Oxygen Generation Plant at Telangana Institute of Medical Sciences (TIMS), Gachibowli. This Oxygen plant works on the principle of Pressure Swing Adsorption and enables efficient distribution of Oxygen for the needy patients. The plant is capable of suppling Oxygen to 70 patients at a time. IIL had taken up this initiative as part of their Corporate Social Responsibility (CSR) and executed it through Sambhav Foundation, an initiative of LabourNet, a Bangalore based Social Enterprise. The cost of the plant is Rs. 1 Crore.

Speaking on the occasion, Dr Vimala Thomas, Director, TIMS, had thanked IIL for this timely support. Dr Vimala Thomas had mentioned that with this installation, TIMS is significantly equipped to treat the patients in need of Oxygen support, specifically suffering from COVID related complications.

Dr. K Anand Kumar, Managing Director, IIL thanked TIMS for providing an opportunity to serve. He thanked the medical fraternity and the staff at TIMS for their tireless efforts in treating COVID patients. Dr. Priyabrata Pattnaik, Deputy Managing Director, IIL, also participated in the event.

About Indian Immunologicals Limited (IIL)

Indian Immunologicals Limited headquartered in Hyderabad, India is one of the largest producers of vaccines in Asia. IIL was setup by National Dairy Development Board (NDDB) in 1982. IIL has multiple GMP manufacturing sites and exports to over 50 countries. IIL has a strong R&D pipeline and has launched several animal and human vaccines in the Indian market at affordable prices. IIL specializes in the development of various types of vaccines ranging from inactivated and live viral vaccines, polysaccharide conjugate vaccines, recombinant subunit vaccines, toxoid vaccines, live bacterial vaccines. More details about the company can be viewed on www.indimmune.com.

About Telangana Institute of Medical Sciences (TIMS) and Research

Telangana Institute of Medical Sciences and Research, Hyderabad (Abbreviated TIMS) is a dedicated COVID-19 hospital in Telangana, India. It is later to be developed as a medical school and public hospital. The hospital came into existence with the issue of G.O.Ms.No. 22, Health, Medical and Family Welfare Department on 25 April 2020. In view of COVID-19 pandemic in India, it was decided by the Government of Telangana to establish a hospital in the Sports Hostel Building at G.M.C Balayogi Athletic Stadium, Gachibowli, Ranga Reddy District to provide health services.

___________________________________________________________________

Latest stories

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back